Inspiration Healthcare PLC’s results today underline the progress it has made with both acquisitions and its neonatal strategy, said Cenkos.
Interim revenues rose by 47%, supported by the contribution of SLE, acquired in July 2020, while gross margin improved to 52.5% from 51.4% and underlying profits jumped by 42%.
“We believe these results clearly demonstrate the group-level benefits from both recent acquisitions (SLE and Viomedex) generating revenue synergies and margin improvements,” said Cenkos.
The broker has upgraded its 2022 estimates by 12% to £3.5mln from £3.2mln, reflecting improved gross margin and lower cash-based costs.
Buy says the broker, with the shares today up by 8% to 126.5p.